Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Receivables (2018 - 2025)

Historic Change in Receivables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $628000.0.

  • Dna X's Change in Receivables rose 12311.37% to $628000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $515000.0, marking a year-over-year increase of 10382.5%. This contributed to the annual value of -$7.4 million for FY2024, which is 34297.03% down from last year.
  • Dna X's Change in Receivables amounted to $628000.0 in Q3 2025, which was up 12311.37% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Change in Receivables ranged from a high of $11.0 million in Q3 2022 and a low of -$6.5 million during Q1 2024
  • For the 5-year period, Dna X's Change in Receivables averaged around $743105.3, with its median value being $649000.0 (2025).
  • Over the last 5 years, Dna X's Change in Receivables had its largest YoY gain of 90264.71% in 2021, and its largest YoY loss of 82965.88% in 2021.
  • Over the past 5 years, Dna X's Change in Receivables (Quarter) stood at $8.2 million in 2021, then fell by 24.88% to $6.1 million in 2022, then tumbled by 179.43% to -$4.9 million in 2023, then skyrocketed by 124.91% to $1.2 million in 2024, then crashed by 48.4% to $628000.0 in 2025.
  • Its Change in Receivables stands at $628000.0 for Q3 2025, versus -$2.0 million for Q2 2025 and $649000.0 for Q1 2025.